Smoking Cessation

2020. Initiating Pharmacologic Treatment in Tobacco-Dependent Adults (ATS)

Seven recommendations are provided, which represent simple practice changes that are likely to increase the effectiveness of tobacco-dependence pharmacotherapy.(1) For tobacco-dependent adults in whom treatment is being initiated, we recommend (1) varenicline over a nicotine patch (2) varenicline over varenicline (3) plus a nicotine patch over varenicline alone (4) varenicline over electronic cigarettes (5) clinicians begin treatment with varenicline rather than waiting until patients are ready to stop tobacco use in those patients who are not ready to discontinue tobacco use (6) varenicline over a nicotine patch in patients with comorbid psychiatric conditions, including substance-use disorder, depression, anxiety, schizophrenia, and/or bipolar disorder (7) using extended-duration (>12 wk) over standard-duration (6–12 wk) therapy

2020. Smoking Cessation: A report of the Surgeon General (CDC)

Tobacco smoking is the leading cause of preventable disease, disability, and death in the United States. The majority of cigarette smokers (68%) want to quit smoking completely. This report includes updates on scientific evidence about smoking cessation and provides new opportunities and challenges for understanding and promoting smoking cessation in the United States.

2019. Tobacco Harm Reduction (ERS)

The epidemic of disease caused by smoking in the 20th century ranks among the greatest public health catastrophes of the last century, and it has been estimated that smoking will kill around one billion people in the 21st century. A harm reduction strategy for smokers includes recommending the use of alternative nicotine delivery products such as smokeless tobacco, e-cigarettes or new heated tobacco products to smokers instead of conventional cigarettes, thus replacing a very harmful product with a less, but still, harmful product. This document presents seven arguments for why a harm reduction strategy should not be used as a population-based strategy in tobacco control.

2019. Global Tobacco Epidemic – Offer help to quit tobacco use (WHO)

Progress in global tobacco control has been strong since MPOWER was introduced in 2007 as a tool to help countries implement WHO FCTC demand reduction measures. Five billion people
– about 65% of the world’s population – are now covered by at least one MPOWER measure at the highest level of achievement. Offering help to quit is an essential component of any tobacco control strategy.

2018. Stop smoking interventions and services (NICE)

This guideline covers stop smoking interventions and services delivered in primary care and
community settings for everyone over the age of 12. It aims to ensure that everyone who smokes is advised and encouraged to stop and given the support they need. It emphasises the importance of targeting vulnerable groups who find smoking cessation hard or who smoke a lot.